Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Core Diagnostics to Offer Precipio's Liquid Biopsy Tests in India

Core Diagnostics to Offer Precipio's Liquid Biopsy Tests in India

Mar 26, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Precipio said today that India's Core Diagnostics will now offer liquid biopsy testing using Precipio's ICE COLD-PCR technology to major hospital networks throughout India and the surrounding region.

Financial terms of the laboratory services agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

  2. FIND Awarded $60M to Expand COVID-19 Testing

  3. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  4. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

  5. PerkinElmer Multianalyte SARS-CoV-2, Flu Test Gets CE Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.